Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Neuropace Inc

NPCE ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Advanced Medical Equipment & Technology ·

USA Small Cap Analyst: BUY

Last Close

$14.77

▲ +1.79%

Market Cap $506.97M · Vol 61.06K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$506.97M

Small Cap

Div Yield

N/A

EPS Growth

+8.23%

YoY

RSI (14)

45.92

Momentum

Beta

1.93

vs Market

52W High

$19.60

24.64% below

52W Low

$8.19

80.34% above

Volume

61.06K

Avg 76.07K

P/B

27.24

Price-to-book

ROE

-158.75%

Return on equity

Free Float

76.96%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Neuropace Inc (NPCE) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does NPCE pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-0.40%

-6.76%

-6.46%

-1.86%

YTD

-4.34%

+63.57%

+228.22%

-28.13%

Financials & Valuation

TTM · Annual

Total Revenue	$99.99M
Net Income	$-21,465,000.00
Revenue Growth (YoY)	+17.05%
Gross Margin	77.23%
Operating Margin	-16.34%
Net Profit Margin	-21.47%
ROE	-158.75%
ROA · ROIC	-21.44% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	5.05
P/B	27.24
P/FCF	N/A
EPS Growth	+8.23%
Outstanding Shares	34.32M

Technical Indicators

50-Day SMA	$15.49
200-Day SMA	$15.28
RSI (14)	45.92
Beta	1.93
52-Week High	$19.60
52-Week Low	$8.19

Volume Today	61.06K
Avg Daily Volume (30D)	76.07K
Relative Volume	0.80x
Volatility (10D)	48.47
Volatility (30D)	65.07
Free Float	76.96%

Analyst Consensus

BUY

Current Price $14.77

Mean Target $20.22

52W Low$8.19 52W High$19.60

Current

Target

$8.19 $19.60

Current Analyst target

+36.91% upside potential · 9 analysts

Identifiers

ExchangeNasdaq

FIGIBBG001V0SVB1

ISINUS6412881053

CountryUnited States of America

Sub-IndustryAdvanced Medical Equipment & Technology (NEC)

Earnings DateNov 8, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

TMO Thermo Fisher Scientific Inc -1.28% DHR Danaher Corp -0.71% ISRG Intuitive Surgical Inc -1.68% BSX Boston Scientific Corp +0.27% EW Edwards Lifesciences Corp -1.04%

Company Profile

NeuroPace, Inc. is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. The Company's RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders. The Company's RNS System includes its RNS neurostimulator, its cortical strip leads and depth leads, and its Patient Remote Monitor, as well as other implantable and non-implantable accessories. The Company's product offerings also include Physician Tablet, Patient Data Management System (PDMS) and nSight Platform, which facilitate ongoing patient monitoring and streamline patient support. The PDMS is an online database.